share_log

Additional Considerations Required While Assessing Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Strong Earnings

Additional Considerations Required While Assessing Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Strong Earnings

在評估深圳容大光敏科技(SZSE: 300576)的強勁收益時需要考慮其他因素
Simply Wall St ·  04/20 21:08

Despite announcing strong earnings, Shenzhen RongDa Photosensitive Science & Technology Co., Ltd.'s (SZSE:300576) stock was sluggish. We did some digging and found some worrying underlying problems.

儘管宣佈了強勁的收益,但深圳榮達光敏科技有限公司's (SZSE: 300576) 股價低迷。我們進行了一些挖掘,發現了一些令人擔憂的潛在問題。

earnings-and-revenue-history
SZSE:300576 Earnings and Revenue History April 21st 2024
SZSE: 300576 2024 年 4 月 21 日的收益和收入歷史記錄

Zooming In On Shenzhen RongDa Photosensitive Science & Technology's Earnings

放大深圳容大光敏科技的收益

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. The ratio shows us how much a company's profit exceeds its FCF.

許多投資者尚未聽說過現金流的應計比率,但它實際上是衡量公司在給定時期內自由現金流(FCF)在多大程度上支持利潤的有用指標。簡而言之,該比率從淨利潤中減去FCF,然後將該數字除以該時期公司的平均運營資產。該比率向我們顯示了公司的利潤超過其FCF的程度。

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

因此,負應計比率對公司來說是正數,而正應計比率是負數。這並不意味着我們應該擔心應計比率爲正,但值得注意的是,應計比率相當高的地方。這是因爲一些學術研究表明,高應計率往往會導致利潤下降或利潤增長減弱。

For the year to December 2023, Shenzhen RongDa Photosensitive Science & Technology had an accrual ratio of 0.38. Statistically speaking, that's a real negative for future earnings. To wit, the company did not generate one whit of free cashflow in that time. In the last twelve months it actually had negative free cash flow, with an outflow of CN¥185m despite its profit of CN¥85.5m, mentioned above. It's worth noting that Shenzhen RongDa Photosensitive Science & Technology generated positive FCF of CN¥60m a year ago, so at least they've done it in the past. Having said that, there is more to the story. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part. One positive for Shenzhen RongDa Photosensitive Science & Technology shareholders is that it's accrual ratio was significantly better last year, providing reason to believe that it may return to stronger cash conversion in the future. Shareholders should look for improved cashflow relative to profit in the current year, if that is indeed the case.

截至2023年12月的一年中,深圳容大光敏科技的應計比率爲0.38。從統計學上講,這對未來的收益來說確實是負面的。換句話說,該公司在那段時間內沒有產生一點自由現金流。在過去的十二個月裏,它實際上有 負面的 自由現金流,儘管利潤爲8,550萬元人民幣,但流出量仍爲1.85億元人民幣,如上所述。值得注意的是,深圳容大光敏科技一年前創造了6000萬元人民幣的正FCF,因此至少他們過去曾這樣做過。話雖如此,故事還有更多。應計比率至少部分反映了不尋常項目對法定利潤的影響。對深圳榮達光敏科技股東來說,一個積極因素是,其去年的應計比率明顯改善,這使人們有理由相信它未來可能會恢復更強勁的現金轉化率。如果確實如此,股東應尋求在本年度的現金流相對於利潤的改善。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Shenzhen RongDa Photosensitive Science & Technology.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對深圳榮達光敏科技的資產負債表分析。

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

Unfortunately (in the short term) Shenzhen RongDa Photosensitive Science & Technology saw its profit reduced by unusual items worth CN¥21m. In the case where this was a non-cash charge it would have made it easier to have high cash conversion, so it's surprising that the accrual ratio tells a different story. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If Shenzhen RongDa Photosensitive Science & Technology doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

不幸的是(在短期內),深圳容大光敏科技的利潤因價值2100萬元人民幣的不尋常項目而減少。如果這是一筆非現金費用,則可以更輕鬆地實現高現金轉換,因此令人驚訝的是,應計比率講述了一個不同的故事。看到不尋常的項目使公司利潤付出代價從來都不是一件好事,但從好的方面來看,情況可能遲早會好轉。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。而且,畢竟,這正是會計術語的含義。如果深圳容大光敏科技沒有看到這些不尋常的支出重演,那麼在其他條件相同的情況下,我們預計其利潤將在來年增加。

Our Take On Shenzhen RongDa Photosensitive Science & Technology's Profit Performance

我們對深圳容大光敏科技盈利表現的看法

Shenzhen RongDa Photosensitive Science & Technology saw unusual items weigh on its profit, which should have made it easier to show high cash conversion, which it did not do, according to its accrual ratio. Having considered these factors, we don't think Shenzhen RongDa Photosensitive Science & Technology's statutory profits give an overly harsh view of the business. If you want to do dive deeper into Shenzhen RongDa Photosensitive Science & Technology, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 2 warning signs for Shenzhen RongDa Photosensitive Science & Technology (of which 1 is significant!) you should know about.

深圳容大光敏科技發現了不尋常的項目壓制了其利潤,這本來可以更容易地顯示出高現金轉化率,而根據其應計比率,深圳榮達光敏科技沒有這樣做。考慮到這些因素,我們認爲深圳容大光敏科技的法定利潤對該業務的看法並不過於嚴厲。如果你想更深入地了解深圳容大光敏科技,你還需要研究它目前面臨的風險。每家公司都有風險,我們已經發現了深圳容大光敏科技的兩個警告信號(其中一個很重要!)你應該知道。

In this article we've looked at a number of factors that can impair the utility of profit numbers, as a guide to a business. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

在這篇文章中,我們研究了許多可能損害利潤數字效用的因素,以此作爲企業的指南。但是,還有很多其他方法可以讓你對公司的看法。有些人認爲高股本回報率是優質業務的好兆頭。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論